The Case ∣ A Senegalese man with gross hematuria  by Hocqueloux, Laurent et al.
Kidney International (2009) 75, 125–126; doi:10.1038/ki.2008.465
The Case | A Senegalese man with gross hematuria
Laurent Hocqueloux1, Re´my Kerdraon2, Mohamadou Niang1 and Olivier Gre´zard3
1Infectious and Tropical Diseases Department, La Source Hospital, Orle´ans, France; 2Department of Pathology, La Source Hospital, Orle´ans,
France and 3Nephrology Ward, La Source Hospital, Orle´ans, France
Correspondence: Laurent Hocqueloux, Service des Maladies Infectieuses et Tropicales, CHR d’Orle´ans La Source, BP 86709, Orle´ans 45067
Cedex 2, France. E-mail: laurent.hocqueloux@chr-orleans.fr
A 36-year-old Senegalese man was referred to the nephrology
service for intermittent gross hematuria for several months.
He had no significant past medical history and had never
smoked. He had resided in France for 5 years but previously
had been working in Gabon. The patient denied any history
of fever, sweats, pruritus, or abdominal pain. Physical
examination was unremarkable. Blood pressure was 125/
78 mm Hg. White cell count revealed mild eosinophilia (810
per ml, No650). Liver tests and renal function were normal
(creatinine clearance was 130 ml/min). Schistosomiasis and
HIV serologies were negative. Urine protein was 0.32 g/day.
Urine and stool parasitologic examinations did not reveal
schistosoma eggs. Chest radiograph, plain film of the
abdomen, and renal ultrasonography were normal. Glomer-
ular disease was suspected: patient underwent a renal biopsy
that failed to show any glomerular pathology. Immunofluor-
escence with anti-immunoglobulin A (IgA), IgG, IgM, C1q,
C3, l and k-chain, fibrin, and albumin was negative.
However, abnormalities were seen in some glomerular
capillaries (Figure 1) and renal arterioles.
What was the cause of his hematuria?
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Figure 1 | Parasitic form (black arrow) in the afferent arteriole of a
glomerulus (periodic acid Schiff, original magnification  400).
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The Diagnosis | Loiasis
Intravascular forms were identified as loiasis (Figure 2). Fresh
blood sample confirmed a massive microfilarial load (8000
Loa loa per ml), whereas filarial serology was negative. The
patient was hospitalized to initiate antifilarial treatment. He
received 12 mg of ivermectin on day 1, then 25 mg of
diethylcarbamazine (DEC) on day 2. Prednisone (1 mg/kg/
day) was added to minimize the risk of drug-induced Loa
encephalopathy. Nevertheless he experienced fever (39.2 1C)
and profound encephalopathy (Glasgow Coma Scale¼ 9/15)
within hours following DEC intake. Simultaneously a
significant rise in proteinuria (up to 2 g/day) was noted.
Loa loa microfilariae (mff) were found in both cerebrospinal
fluid and urine. DEC was stopped, prednisone was
continued, and the patient was admitted to the intensive
care unit for 10 days. The patient progressively recovered
without sequelae. Six weeks later, a second course of DEC
(beginning with very low doses: 3 mg/day, doubling daily up
to 400 mg) was started, leading to blood sterilization and
complete normalization of eosinophilia and urine sediment.
The patient did not exhibit further episodes of hematuria.
Visceral manifestations of loiasis, as encephalopathy and
renal impairment, are well described and are attributable
mainly to antifilarial treatment;1 spontaneous cases of
visceral complications are rare.2
Loiasis can be associated with hematuria, proteinuria, and,
infrequently, the nephrotic syndrome and renal failure.1
Membranous and membranoproliferative glomerulonephri-
tis, which are associated with the deposition of immune
complexes, have been described in this setting. Renal
impairment following a single dose of ivermectin3,4 or DEC
treatment1 have been reported. These adverse effects are
thought to be immunologically mediated and could be the
consequence of a massive liberation of filarial antigens
following therapy. Encephalopathy is often fatal or leads to
serious neurological sequelae. Most patients who develop Loa
encephalopathy following treatment have very high micro-
filarial loads, exceeding 30,000 mff/ml, but a risk exists after
ivermectin as soon as the threshold of 8000 mff/ml is
reached.1 No specific treatment for the management of
these severe adverse effects has yet been identified. Mechan-
isms remain unclear, but pathological findings in an animal
model suggest that the occlusion of cerebral capillaries
due to numerous mff damaged or paralyzed by the drug
may be the cause of encephalopathy.1 Massive release of
antigens or endotoxins, consecutive to parasitic destruction,
may also be involved in this setting, as well as in kidney
involvement.1
Hematuria in a patient coming from an endemic area of
loiasis (i.e., Central Africa) should lead to the examination of
blood to confirm the diagnosis, as serology may be false
negative in this setting. Renal microvascular involvement may
be the only manifestation of infestation. A very careful
introduction of antifilarial drugs should be performed to
avoid life-threatening Loa encephalopathy.
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Figure 2 | Microfilariae (black arrows) in the lumen of a renal
arteriole (Masson’s Trichrome, original magnification 400).
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